Hilltop Bio
6 known investors
Hilltop Bio develops regenerative biologic therapies for veterinary medicine, using its proprietary BioStabyl process to preserve biological components such as exosomes, extracellular matrix proteins, and growth factors. Its products are used by veterinarians to manage soft tissue injuries and support post-surgical recovery in small animals and equine patients.
BiotechHealthtech
Investors · 6
Frequently asked questions
- What does Hilltop Bio do?
- Hilltop Bio develops regenerative biologic therapies for veterinary medicine, using its proprietary BioStabyl process to preserve biological components such as exosomes, extracellular matrix proteins, and growth factors. Its products are used by veterinarians to manage soft tissue injuries and support post-surgical recovery in small animals and equine patients.
- Who are Hilltop Bio's investors?
- Hilltop Bio's investors include Band of Angels, Beacon Angels, Launchpad Venture Group, RevUp Capital, Walnut Venture Associates, Golden Seeds.